Santhera Enters into License Agreement with Chiesi Group for Raxone® for the treatment of LHON

Transaction allows Santhera to advance its long-term growth strategy by focusing on the development of its clinical-stage neuromuscular and pulmonary programs Santhera Pharmaceuticals announces that it has entered into an exclusive license agreement with Chiesi Farmaceutici, an international researchfocused healthcare group (Chiesi Group), under which Chiesi Group will in-license Raxone® for the treatment of LHON

Read More


Proof It’s Possible to Enhance or Suppress Memories

Boston University neuroscientist shows that stimulating different parts of the brain can dial up or down a specific memory’s emotional oomph What if scientists could manipulate your brain so that a traumatic memory lost its emotional power over your psyche? Steve Ramirez (CAS’10), a Boston University neuroscientist fascinated by memory, believes that a small structure in the

Read More


Human Hippocampal Neurogenesis Persists in Aged Adults and Alzheimer’s Disease Patients

Whether hippocampal neurogenesis persists throughout life in the human brain is not fully resolved. Researchers of the Department of Anatomy and Cell Biology, University of Illinois at Chicago, Chicago, IL, USA demonstrate in a just published paper on Cell Stem Cell that hippocampal neurogenesis is persistent through the tenth decade of life and is detectable

Read More


Allogeneic stem cell transplantation in non-Hodgkin lymphoma: benefit remains unclear

Meaningful studies are lacking for certain patient groups / Disease-specific registries could help close the data gap The German Institute for Quality and Efficiency in Health Care (IQWiG) has investigated whether patients suffering from non-Hodgkin lymphoma have (better) chances of recovery when stem cells from another person are transplanted. In its final report now presented,

Read More